Immune Function and Response to Vaccination After Cancer Therapy in Pediatric Patients (NCT04948619)
Immune Function and Response to Vaccination Following Completion of Cancer Directed Systemic Therapy in Pediatric Patients With Cancer
🩺 Plain-English Summary (8th-Grade Level)
Pediatric cancer survivors have increased infection-related morbidity and mortality. This study will evaluate immune dysfunction following cancer directed systemic therapy completion, with attention to clinical relevance and infection rate in this population compared to healthy siblings, when applicable. The investigators will also restart vaccinations at earlier time points than previously studied, at 3 months post therapy, and will assess whether boosters or revaccination schedules are superior for regaining immunity against potentially serious infections in survivors.
Who can join: Review the eligibility criteria below.
Location: Levine Cancer Institute — Charlotte, North Carolina
Age range: 2 Years to 21 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Levine Cancer Institute — Charlotte, North Carolina
📞 Contact the Study Coordinator
Phone: (980) 442-2323
Email: Sceria.Jenkins@advocatehealth.org
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Pediatric Cancer
- Enrollment on the Childhood Cancer Research Network (CCRN) of the Children's Oncology Group — Arcadia, California
- Barriers and Facilitators in Access to OT/PT in Pediatric Cancer Survivors — Houston, Texas
- Estimating Setup Uncertainty in Pediatric Proton Therapy Using Volumetric Images — Memphis, Tennessee
- ATOMIC Mobile App to Increase Physical Activity (PA) Levels in Survivors of Childhood Cancer — Hartford, Connecticut
- Durvalumab and Tremelimumab for Pediatric Malignancies — Baltimore, Maryland
- Medically Tailored Meals for Kids — Chapel Hill, North Carolina
Explore by condition: All Pediatric Cancer clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.